Penicillamine - CAS 52-67-5
Catalog number: B0084-070545
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C5H11NO2S
Molecular Weight:
149.21
COA:
Inquire
Targets:
Others
Description:
Penicillamine is used as an antirheumatic and as a chelating agent in Wilson’s disease.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-070545 100 g $249 In stock
Bulk Inquiry
Purity:
>98%
Synonyms:
Dimethyl Cysteine
MSDS:
Inquire
InChIKey:
VVNCNSJFMMFHPL-VKHMYHEASA-N
InChI:
InChI=1S/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)/t3-/m0/s1
Canonical SMILES:
CC(C)(C(C(=O)O)N)S
1.Optically active red-emitting Cu nanoclusters originating from complexation and redox reaction between copper(ii) and d/l-penicillamine.
Long T1, Guo Y1, Lin M1, Yuan M1, Liu Z1, Huang C1. Nanoscale. 2016 Apr 27. [Epub ahead of print]
Despite a significant surge in the number of investigations into both optically active Au and Ag nanostructures, there is currently only limited knowledge about optically active Cu nanoclusters (CuNCs) and their potential applications. Here, we have succeeded in preparing a pair of optically active red-emitting CuNCs on the basis of complexation and redox reaction between copper(ii) and penicillamine (Pen) enantiomers, in which Pen serves as both a reducing agent and a stabilizing ligand. Significantly, the CuNCs feature unique aggregation induced emission (AIE) characteristics and therefore can serve as pH stimuli-responsive functional materials. Impressively, the ligand chirality plays a dramatic role for the creation of brightly emissive CuNCs, attributed to the conformation of racemic Pen being unfavorable for the electrostatic interaction, and thus suppressing the formation of cluster aggregates. In addition, the clusters display potential toward cytoplasmic staining and labelling due to the high photoluminescence (PL) quantum yields (QYs) and remarkable cellular uptake, in spite that no chirality-dependent effects in autophagy and subcellular localization are observed in the application of chiral cluster enantiomer-based cell imaging.
2.Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.
Chandhok G1, Horvath J1, Aggarwal A1, Bhatt M1, Zibert A1, Schmidt HH1. World J Gastroenterol. 2016 Apr 28;22(16):4109-19. doi: 10.3748/wjg.v22.i16.4109.
AIM: To study the effect of anti-copper treatment for survival of hepatic cells expressing different ATP7B mutations in cell culture.
3.Transition-Metal-Mediated Release of Nitric Oxide (NO) from S-Nitroso-N-acetyl-d-penicillamine (SNAP): Potential Applications for Endogenous Release of NO at the Surface of Stents Via Corrosion Products.
McCarthy CW1, Guillory RJ 2nd1, Goldman J1, Frost MC1. ACS Appl Mater Interfaces. 2016 Apr 27;8(16):10128-35. doi: 10.1021/acsami.6b00145. Epub 2016 Apr 18.
Nitric oxide (NO), identified over the last several decades in many physiological processes and pathways as both a beneficial and detrimental signaling molecule, has been the subject of extensive research. Physiologically, NO is transported by a class of donors known as S-nitrosothiols. Both endogenous and synthetic S-nitrosothiols have been reported to release NO during interactions with certain transition metals, primarily Cu(2+) and Fe(2+). Ag(+) and Hg(2+) have also been identified, although these metals are not abundantly present in physiological systems. Here, we evaluate Pt(2+), Fe(2+), Fe(3+), Mg(2+), Zn(2+), Mn(2+), Co(2+), Ni(2+), and Cu(2+) for their ability to generate NO from S-nitroso-N-acetyl-d-penicillamine (SNAP) under physiological pH conditions. Specifically, we report NO generation from RSNOs initiated by three transition metal ions; Co(2+), Ni(2+), and Zn(2+), which have not been previously reported to generate NO. Additionally, preliminary in vivo evidence of zinc wires implanted in the rat arterial wall and circulating blood is presented which demonstrated inhibited thrombus formation after 6 months.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 83207-58-3 Astragaloside A

Astragaloside A
(CAS: 83207-58-3)

Astragaloside A (Astragaloside IV) is the primary pure saponin isolated from Astragalus membranaceus, which has been widely used for the treatment of cardiovasc...

CAS 918633-87-1 Evofosfamide

Evofosfamide
(CAS: 918633-87-1)

Evofosfamide is a hypoxia-activated prodrug consisting of a 2-nitroimidazole phosphoramidate conjugate with potential antineoplastic activity. The 2-nitroimidaz...

CAS 2646-71-1 NADPH tetrasodium salt

NADPH tetrasodium salt
(CAS: 2646-71-1)

NADPH tetrasodium salt is an ubiquitous coenzyme that acts as an electron donor in various biological reactions.<br/>Nutritional supplement in health care produ...

CAS 485-72-3 Formononetin

Formononetin
(CAS: 485-72-3)

Formononetin is a phytoestrogen from the root of Astragalus membranaceus and an O-methylated isoflavone.

CAS 147591-46-6 ID-8

ID-8
(CAS: 147591-46-6)

ID-8 is a DYRK inhibitor, and sustains embryonic stem cell self-renewal in long-term culture.

Amifampridine Phosphate
(CAS: 446254-47-3)

Amifampridine is a drug, predominantly used to treat many of the congenital myasthenic syndromes, particularly those with defects in choline acetyltransferase, ...

CAS 871085-49-3 TCS 3035

TCS 3035
(CAS: 871085-49-3)

TCS 3035 is a GPR35 agonist (pEC50 = 5.13 and 5.86 for rat and human GPR35 orthologs, respectively).

CAS 57852-42-3 Resiniferonol 9,13,14-Orthophenylacetate

Resiniferonol 9,13,14-Orthophenylacetate
(CAS: 57852-42-3)

Resiniferonol 9,13,14-Orthophenylacetate, a 20-Deacylated derivative of resiniferatoxin and tinyatoxin, is a transient receptor potential vanilloid-1 (TRPV1) ag...

Chemical Structure

CAS 52-67-5 Penicillamine

Quick Inquiry

Verification code

Featured Items